⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

October 17, 2007Journal of Nuclear MedicineOpen Access

The National Oncologic PET Registry (NOPR): Design and Analysis Plan

View Full Paper

Ask AI

Bookmark

Share

Abstract

The NOPR will allow an accurate assessment of the impact of PET on intended patient management across a wide spectrum of cancer indications.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hillner et al. (2007) studied this question.

synapsesocial.com/papers/69daa43b84371aa676a3d948 https://doi.org/10.2967/jnumed.107.043687

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

1Patients with known or suspected lung cancer: evaluation of clinical management changes due to 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) studyPrognostic Study · 2005 · 11 citations
2Impact of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography on Patient Management: First Year’s Experience in a Clinical CenterOriginal Research · 2001 · 45 citations
3The National Oncologic PET Registry: Expanded Medicare Coverage for PET Under Coverage with Evidence DevelopmentRegistry Study · 2007 · 59 citations